Weight Loss Injections Mounjaro

Access to Tirzepatide (Mounjaro) for Weight Loss

The new weight management ‘Tirzepatide’ medication (brand name Mounjaro®) is shortly being made available to NHS patients to support weight loss.

We’re currently in the process of establishing new community-based weight management services. 

We’ll update this page and share information with local partners as soon as the new service is active, so please check back at regular intervals. Please don’t contact your GP before we confirm the new service is available in your area, as they won’t be able to refer you.

Availability of the drug is being made available on a phased basis, with the first group of people eligible under the national criteria being people who: 

• Have a Body Mass Index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)

and

• Have at least four of the following long-term conditions:
  1. Type 2 diabetes
  2. Hypertension (high blood pressure)
  3. Dyslipidaemia
  4. Established cardiovascular disease
  5. Obstructive sleep apnoea

Thank you